POST Online Media Lite Edition


Patrick Vallance appointed to GSK executive leadership team

Staff writer |
London, United Kingdom - May 13, 2010, London, United Kingdom - GlaxoSmithKline (GSK) announced the appointment of Patrick Vallance, as senior vice president, medicines discovery and development and as a member of the company’s corporate executive team both effective from July 1.

Prior to joining GSK in 2006, Mr. Vallance was a clinical academic and led the Division of Medicine at UCL. He has more than 20 years of experience of clinical medicine and has an international reputation as a vascular biologist and clinician scientist.

 LATEST MOVES FROM United Kingdom 

John Lewis Of Hungerford appoints Kiran Noonan as acting chair
Ferroglobe appoints Marco Levi as chief executive officer
Tullow Oil appoints Dorothy Thompson as interim chair
Arla Foods says CFO Natalie Knigh to leave
Superdry promotes Julian Dunkerton to full time CEO

What to read next

Suncorp: Patrick Snowball new CEO
Patrick Hessini joins Avant Energy as VP
Wessex Exploration appoints Iain Patrick as non-executive director